This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tang, X. X. Articles by Ikegaki, N. Search for Related Content PubMed PubMed Citation Articles by Tang, X. X. Articles by Ikegaki, N.

Favorable Neuroblastoma Genes and Molecular Therapeutics of Neuroblastoma

¹ Divisions of Neurology, ² Surgery Research, and ³ Pathology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

Purpose and Experimental Design: Neuroblastoma (NB) is a common pediatric solid tumor that exhibits a striking clinical bipolarity: favorable and unfavorable. Favorable NB genes (EPHB6, EFNB2, EFNB3, NTRK1, and CD44) are genes whose high-level expression predicts favorable NB outcome, and forced expression of these genes inhibits growth of unfavorable NB cells. In this study, we investigated whether favorable NB gene expression could be augmented in unfavorable NB cells by chemical compounds and whether an increased expression of these genes was associated with suppression of NB growth and metastasis.

Results: We found that inhibitors of DNA methylation [5-aza-2'-deoxycytidine (5AdC)], histone deacetylase (HDAC) [4-phenylbutyrate (4PB)], and proteasome (MG262) enhanced the expression of favorable NB genes in NB cell lines and inhibited the growth of these cells in vitro (P < 0.0005). The growth-inhibitory effects of 5AdC and 4PB in vitro were in part due to caspase-dependent cell death and inhibition of DNA synthesis. Administration of 5AdC and/or 4PB also suppressed growth of subcutaneous NB xenografts in nude mice (P < 0.001), which was accompanied by enhanced favorable NB gene expression and an increase in apoptosis. Moreover, 4PB suppressed bone marrow and liver metastases of NB cells in severe combined immunodeficient/Beige mice (P = 0.007 and P = 0.008, respectively). The growth-suppressive activity of HDAC inhibitors on NB was further confirmed by the efficacy of trichostatin A, a potent and specific HDAC inhibitor.

Conclusions: Collectively, these observations further emphasize the link between the elevated favorable NB gene expression and a benign phenotype of NB.

This article has been cited by other articles:

				K. De Preter, S. De Brouwer, T. Van Maerken, F. Pattyn, A. Schramm, A. Eggert, J. Vandesompele, and F. Speleman Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds Clin. Cancer Res., June 1, 2009; 15(11): 3690 - 3696. [Abstract] [Full Text] [PDF]

				Y. Kotliarov, S. Kotliarova, N. Charong, A. Li, J. Walling, E. Aquilanti, S. Ahn, M. E. Steed, Q. Su, A. Center, et al. Correlation Analysis between Single-Nucleotide Polymorphism and Expression Arrays in Gliomas Identifies Potentially Relevant Target Genes Cancer Res., February 15, 2009; 69(4): 1596 - 1603. [Abstract] [Full Text] [PDF]

				N. Ikegaki, T. Gotoh, B. Kung, J. S. Riceberg, D. Y. Kim, H. Zhao, E. F. Rappaport, S. L. Hicks, R. C. Seeger, and X. X. Tang De novo Identification of MIZ-1 (ZBTB17) Encoding a MYC-Interacting Zinc-Finger Protein as a New Favorable Neuroblastoma Gene Clin. Cancer Res., October 15, 2007; 13(20): 6001 - 6009. [Abstract] [Full Text] [PDF]

				N. Keshelava, E. Davicioni, Z. Wan, L. Ji, R. Sposto, T. J. Triche, and C. P. Reynolds Histone Deacetylase 1 Gene Expression and Sensitization of Multidrug-Resistant Neuroblastoma Cell Lines to Cytotoxic Agents by Depsipeptide J Natl Cancer Inst, July 18, 2007; 99(14): 1107 - 1119. [Abstract] [Full Text] [PDF]

				M. Entin-Meer, X. Yang, S. R. VandenBerg, K. R. Lamborn, A. Nudelman, A. Rephaeli, and D. A. Haas-Kogan In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas Neuro-oncol, April 1, 2007; 9(2): 82 - 88. [Abstract] [Full Text] [PDF]

				G. Zupkovitz, J. Tischler, M. Posch, I. Sadzak, K. Ramsauer, G. Egger, R. Grausenburger, N. Schweifer, S. Chiocca, T. Decker, et al. Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1 Mol. Cell. Biol., November 1, 2006; 26(21): 7913 - 7928. [Abstract] [Full Text] [PDF]

				X. X. Tang, H. Zhao, B. Kung, D. Y. Kim, S. L. Hicks, S. L. Cohn, N.-K. Cheung, R. C. Seeger, A. E. Evans, and N. Ikegaki The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma. Cancer Res., March 1, 2006; 66(5): 2826 - 2833. [Abstract] [Full Text] [PDF]

				J. Fan, Y. Chen, H. M. Chan, P. K. H. Tam, and Y. Ren Removing intensity effects and identifying significant genes for Affymetrix arrays in macrophage migration inhibitory factor-suppressed neuroblastoma cells PNAS, December 6, 2005; 102(49): 17751 - 17756. [Abstract] [Full Text] [PDF]

				J. Hsieh, K. Nakashima, T. Kuwabara, E. Mejia, and F. H. Gage Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells PNAS, November 23, 2004; 101(47): 16659 - 16664. [Abstract] [Full Text] [PDF]